GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UFP Technologies Inc (NAS:UFPT) » Definitions » Debt-to-EBITDA

UFP Technologies (UFP Technologies) Debt-to-EBITDA : 0.74 (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is UFP Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

UFP Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $7.2 Mil. UFP Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $38.8 Mil. UFP Technologies's annualized EBITDA for the quarter that ended in Dec. 2023 was $62.4 Mil. UFP Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.74.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for UFP Technologies's Debt-to-EBITDA or its related term are showing as below:

UFPT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.05   Med: 0.18   Max: 2.85
Current: 0.67

During the past 13 years, the highest Debt-to-EBITDA Ratio of UFP Technologies was 2.85. The lowest was 0.05. And the median was 0.18.

UFPT's Debt-to-EBITDA is ranked better than
62.47% of 429 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs UFPT: 0.67

UFP Technologies Debt-to-EBITDA Historical Data

The historical data trend for UFP Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UFP Technologies Debt-to-EBITDA Chart

UFP Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.09 2.85 1.02 0.67

UFP Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.20 0.90 0.80 0.74

Competitive Comparison of UFP Technologies's Debt-to-EBITDA

For the Medical Devices subindustry, UFP Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UFP Technologies's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where UFP Technologies's Debt-to-EBITDA falls into.



UFP Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

UFP Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.222 + 38.815) / 68.954
=0.67

UFP Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.222 + 38.815) / 62.432
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


UFP Technologies  (NAS:UFPT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


UFP Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of UFP Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


UFP Technologies (UFP Technologies) Business Description

Traded in Other Exchanges
Address
100 Hale Street, Newburyport, MA, USA, 01950-3504
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing highly specialized foams, films, and plastics primarily for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Executives
R Jeffrey Bailly director, 10 percent owner, officer: President and CEO 100 HALE STREET, NEWBURYPORT MA 01950
Mitchell Rock officer: Vice President C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833
Jason Holt officer: Vice President 100 HALE STREET, NEWBURYPORT MA 01950
Symeria Hudson director 100 HALE STREET, NEWBURYPORT MA 01950
Joseph Hassett director ONE TECHNOLOGY WAY, NORWOOD MA 02062
Daniel C Croteau director C/O LYNCH, BREWER, HOFFMAN & FINK, LLP, 75 FEDERAL STREET, 7TH FLOOR, BOSTON MA 02110
Cynthia L Feldmann director 17 WINTHROP ROAD, WAYLAND MA 01778
Christopher P. Litterio officer: Senior Vice President C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT MA 02143
Ronald J Lataille officer: Chief Financial Officer
Thomas Oberdorf director C/O GETTY IMAGES, INC., 601 N 34TH ST, SEATTLE WA 98103
Marc D Kozin director
Steve Cardin officer: Vice President 100 HALE STREET, NEWBURYPORT MA 01950
Daniel J Shaw officer: Vice President
W David Smith officer: Vice President 172 EAST MAIN STREET, GEORGETOWN MA 01833
Pierce Robert W Jr director C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833

UFP Technologies (UFP Technologies) Headlines